BridgeBio Oncology Therapeutics: Oppenheimer cuts target price to $16 from $22
BBOT•Oppenheimer cut its target price for BridgeBio Oncology Therapeutics to $16 from $22.
Related News
LiqTech secures order for two marine water treatment units in China
LIQT•
UK mid-market business growth hits 22-month high in September, NatWest says
NWG•
Amazon to add 300,000 new US jobs this holiday season
AMZN•
Conduent partners with New Jersey to roll out chip-enabled EBT cards
CNDT•
Novo Nordisk's CagriSema linked to 25% weight loss in women in post hoc trial analysis
NVO•